Get your orders in 8 hours Dhaka city and 24 hours in other districts! ৮ ঘণ্টায় ঢাকা শহরে ও ২৪ ঘণ্টায় ঢাকার বাহিরে ডেলিভারি

Upload Prescription
0 Items
0

Due to the COVID 19 epidemic, orders may be processed with a slight delay

Home Health Conditions Cancer/oncology Palbocent 125 mg Capsule (Box)
thumbnail

Palbocent 125 mg Capsule (Box)

21 Capsule, Generic Name: Palbociclib 125 mg. Manufacturer:  Incepta Pharmaceuticals Limited

MRP 8400 8% off
7728
Inclusive of all taxes

Information about Palbocent 125 mg Capsule (Box)

Palbociclib is a kinase inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:

  • An aromatase inhibitor as initial endocrine based therapy in postmenopausal women; or
  • Fulvestrant in women with disease progression following endocrine therapy.

Dosage: Palbociclib capsules are taken orally with food in combination with an aromatase inhibitor or fulvestrant.

  • Recommended starting dose: 125 mg once daily taken with food for 21 days followed by 7 days off treatment.
  • Dosing interruption and/or dose reductions are recommended based on individual safety and tolerability. 

Side effect: Most common adverse reactions (incidence ≥10%) were neutropenia, infections, leukopenia, fatigue, nausea, stomatitis, anemia, alopecia, diarrhea, thrombocytopenia, rash, vomiting, decreased appetite, asthenia, and pyrexia.

Ratings & Reviews

No review

Similar Products